A randomized, double-blind, placebo-controlled, multicenter, multinational, phase II trial of L-BLP25 in patients with colorectal carcinoma following R0/R1 hepatic metastasectomy. 2. Juni 2012 Schimanski, C.C., Moehler, M.H., Lang, H., Schoen, M., Smith-Machnow, V., Kanzler, S., Hegewisch-Becker, S., Doerfel, S., Seehofer, D., Bechstein, W., Heike, M., Overkamp, F., Kullmann, F., Voehringer, M., Heinemann, V., von Wichert, G., Kasper, S., Greil, R., Samonigg, H., Galle, P.R., 2012. J Clin Oncol 30 (suppl 15; Abstract 99605). doi: 10.1200/jco.2012.30.15_suppl.tps3641 Abstract Sequential systemic treatments of patients with metastatic renal cell carcinoma in German oncology and onco-urology outpatient centers. Data from the clinical RCC Registry. Müller, L., Goebell, P., Harich, H., Vogt, M., Marschner, N., 2012. Onkologie 35 (suppl 6)(V684), 203. doi:10.1159/000178474 Abstract… Weiterlesen LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases–a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial. Schimanski, C.C., Mohler, M., Schon, M., van Cutsem, E., Greil, R., Bechstein, W.O., Hegewisch-Becker, S., von Wichert, G., Vohringer, M., Heike, M., Heinemann, V., Peeters,… Weiterlesen